<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CD8 T cell infiltration &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cd8-t-cell-infiltration/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 11:59:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>CD8 T cell infiltration &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Targeting Thymidylate Synthase Boosts Cervical Cancer Immunity</title>
		<link>https://bioengineer.org/targeting-thymidylate-synthase-boosts-cervical-cancer-immunity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 11:59:17 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CD8 T cell infiltration]]></category>
		<category><![CDATA[CD8+ T cells]]></category>
		<category><![CDATA[cervical cancer immunotherapy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Thymidylate synthase]]></category>
		<category><![CDATA[Metabolic reprogramming** * **Thymidylate synthase:** Araştırmanın temel hedefi ve ana konusu. * **Cervical cancer immunotherapy:** Çalışmanın odaklandığı spesifik kanser türü ve geliştirilmeye ç]]></category>
		<category><![CDATA[Metabolic-Immune Crosstalk]]></category>
		<category><![CDATA[Thymidylate Synthase Inhibition]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<category><![CDATA[Tumor microenvironment modulation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeting-thymidylate-synthase-boosts-cervical-cancer-immunity/</guid>

					<description><![CDATA[In a groundbreaking study that could dramatically shift the landscape of cervical cancer treatment, researchers have unveiled a promising new therapeutic strategy centered around targeting thymidylate synthase (TS). This pivotal enzyme, essential for DNA synthesis and cell proliferation, has now been linked to the modulation of immune responses within the tumor microenvironment, revealing a compelling [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318296</post-id>	</item>
		<item>
		<title>Scientists Reveal Unexpected Role of ‘Natural Killer’ Cells in Cancer Immunotherapy Resistance</title>
		<link>https://bioengineer.org/scientists-reveal-unexpected-role-of-natural-killer-cells-in-cancer-immunotherapy-resistance/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 18 Jun 2025 14:18:29 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CD8 T cell infiltration]]></category>
		<category><![CDATA[CX3CR1 signaling blockade]]></category>
		<category><![CDATA[Melanoma immunotherapy resistance]]></category>
		<category><![CDATA[Natural Killer cells paradox]]></category>
		<category><![CDATA[Tumor microenvironment immune exclusion]]></category>
		<guid isPermaLink="false">https://bioengineer.org/scientists-reveal-unexpected-role-of-natural-killer-cells-in-cancer-immunotherapy-resistance/</guid>

					<description><![CDATA[In a groundbreaking study poised to reshape the landscape of cancer immunotherapy, researchers at the VIB-KU Leuven Center for Cancer Biology have unveiled a paradoxical role of ‘natural killer’ (NK) cells in melanoma patients resistant to immune checkpoint blockade (ICB) therapies. Traditionally celebrated as potent cytotoxic agents targeting tumor cells, these NK cells may, under [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">249751</post-id>	</item>
	</channel>
</rss>
